Biofrontera, Inc. to Present at the 35th Annual ROTH Conference on March 13, 2023

Rhea-AI Summary

Biofrontera, Inc. (NASDAQ:BFRI), a biopharmaceutical company focused on dermatological treatments, will present at the 35th Annual ROTH Conference in Laguna Nigel, CA, from March 12-14, 2023. CEO Erica Monaco and CFO Fred Leffler will represent the company. Their presentation is scheduled for March 13, 2023, at 8:00 AM PT, and can be viewed live here. An archive will be available after the event. Biofrontera specializes in photodynamic therapy and topical antibiotics for skin conditions, including actinic keratoses and impetigo. For more details, visit www.biofrontera-us.com.

WOBURN, MA / ACCESSWIRE / March 2, 2023 / Biofrontera, Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products will be presenting at the 35^th Annual ROTH Conference in Laguna Nigel, CA being held March 12-14, 2023. Biofrontera, Inc. Chief Executive Officer, Erica Monaco, and Chief Financial Officer, Fred Leffler will represent the company at the conference.

The company presentation will be on March 13, 2023 at 8:00 AM PT and the webcast can be viewed here https://wsw.com/webcast/roth46/b8f.de/1934305. An archive of this webcast will also be available soon after the live presentation. Management will be available for 1x1 meetings during the conference. Please contact your ROTH MKM representative to schedule a meeting.

About Biofrontera Inc.

Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company's licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. For more information, visit www.biofrontera-us.com.

Contacts:

Biofrontera Investor Relations
ir@bfinc.com

SOURCE: Biofrontera Inc.

View source version on accesswire.com:
https://www.accesswire.com/741615/Biofrontera-Inc-to-Present-at-the-35th-Annual-ROTH-Conference-on-March-13-2023

FAQ

When will Biofrontera present at the 35th Annual ROTH Conference?

Biofrontera will present on March 13, 2023, at 8:00 AM PT.

Where is the 35th Annual ROTH Conference taking place?

The conference is being held in Laguna Nigel, CA.

Who from Biofrontera will be presenting at the conference?

CEO Erica Monaco and CFO Fred Leffler will represent Biofrontera.

How can I view Biofrontera's presentation at the ROTH Conference?

The presentation can be viewed live here.

What products does Biofrontera focus on?

Biofrontera specializes in dermatological products, particularly for actinic keratoses and impetigo.

What is the stock symbol for Biofrontera?

The stock symbol for Biofrontera is BFRI.